[Multidisciplinary management of older adults with advanced prostate cancer].
1/5 보강
The percentage of older patients with prostate cancer is increasing progressively.
APA
Molina-Garrido MJ, Ramírez-Martín R, et al. (2026). [Multidisciplinary management of older adults with advanced prostate cancer].. Revista espanola de geriatria y gerontologia, 61(1), 101748. https://doi.org/10.1016/j.regg.2026.101748
MLA
Molina-Garrido MJ, et al.. "[Multidisciplinary management of older adults with advanced prostate cancer].." Revista espanola de geriatria y gerontologia, vol. 61, no. 1, 2026, pp. 101748.
PMID
41713351 ↗
Abstract 한글 요약
The percentage of older patients with prostate cancer is increasing progressively. This population requires specific and specialized, and at the same time, multidisciplinary management. This paper summarizes the scientific evidence available on the therapeutic management of prostate neoplasia in these patients, with the participation of the different specialists involved in this management: urologists, radiation oncologists, nuclear medicine specialists, geriatricians and medical oncologists. Data are presented on the use of chemotherapy, hormonal therapy, radioligands, targeted therapies, and radiotherapy, as well as the most common geriatric conditions in these patients and how to manage them in a specialized manner.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.